5 research outputs found
Design of a continuous production energy machine from marine trochoidal waves
This paper describes the development of a continuous production energy
machine from marine trochoidal waves. Studying the characteristics of trochoidal
waves in a geographical area near Cartagena, we have developed a device, which
taking advantage of the marine surface oscillation in order to produce the movement
of a mechanical device, is able to transforming the mechanical energy into
electrical energy.Peer Reviewe
Modelization of a hybrid system with renewable energy for electric propulsion in boats. Application to a robotic floating platform
A model of a hybrid system with renewable energy for electric propulsion
in boats in which energy generated by photovoltaic panels and hydrogenerator is
stored in the main battery which exerts its function as central element of a renewable
cycle is presented. Additionally, hydrogen plays a role being generated by an
electrolyzer for later to be stored in cylinders aboard in order to generate electric
power by a fuel cell. Both, batteries and cylinders can be used to feed the different elements
of the system, more specially the thruster while the excess of power is stored
in another battery which is auxiliary and it is able to feed the first when it is necessary.Peer Reviewe
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis.
A clear dosing regimen for methotrexate in psoriasis is lacking, and this might lead to a suboptimal treatment. Because methotrexate is affordable and globally available, a uniform dosing regimen could potentially optimize the treatment of patients with psoriasis worldwide.
To reach international consensus among psoriasis experts on a uniform dosing regimen for treatment with methotrexate in adult and pediatric patients with psoriasis and identify potential future research topics.
Between September 2020 and March 2021, a survey study with a modified eDelphi procedure that was developed and distributed by the Amsterdam University Medical Center and completed by 180 participants worldwide (55 [30.6%] resided in non-Western countries) was conducted in 3 rounds. The proposals on which no consensus was reached were discussed in a conference meeting (June 2021). Participants voted on 21 proposals with a 9-point scale (1-3 disagree, 4-6 neither agree nor disagree, 7-9 agree) and were recruited through the Skin Inflammation and Psoriasis International Network and European Academy of Dermatology and Venereology in June 2020. Apart from being a dermatologist/dermatology resident, there were no specific criteria for participation in the survey. The participants worked mainly at a university hospital (97 [53.9%]) and were experienced in treating patients with psoriasis with methotrexate (163 [91.6%] had more than 10 years of experience).
In a survey with eDelphi procedure, we tried to reach consensus on 21 proposals. Consensus was defined as less than 15% voting disagree (1-3). For the consensus meeting, consensus was defined as less than 30% voting disagree.
Of 251 participants, 180 (71.7%) completed all 3 survey rounds, and 58 participants (23.1%) joined the conference meeting. Consensus was achieved on 11 proposals in round 1, 3 proposals in round 2, and 2 proposals in round 3. In the consensus meeting, consensus was achieved on 4 proposals. More research is needed, especially for the proposals on folic acid and the dosing of methotrexate for treating subpopulations such as children and vulnerable patients.
In this eDelphi consensus study, consensus was reached on 20 of 21 proposals involving methotrexate dosing in patients with psoriasis. This consensus may potentially be used to harmonize the treatment with methotrexate in patients with psoriasis